BS EN ISO 22442-3:2007
Current
The latest, up-to-date edition.
Medical devices utilizing animal tissues and their derivatives Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
Hardcopy , PDF
English
29-02-2008
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 General requirements
4.1 Risk management
4.2 Sourcing and manufacturing process
4.3 General requirements related to validation
5 Literature review
5.1 Conduct of the literature review
5.2 Application of literature review output
5.3 Viruses
5.4 TSE agents
6 Elimination and/or inactivation study of viruses and TSE
agents
6.1 General
6.2 Protocol
6.3 Conduct of the study
6.4 Interpretation of data
7 Final report
8 Review of final report
9 Routine monitoring and control of critical process parameters
Annex A (normative) - Requirements related to literature review
Annex B (informative) - Guidance on the elimination and/or
inactivation study for viruses
Annex C (informative) - Guidance on the elimination and/or
inactivation study for TSE agents
Annex D (informative) - Guidance on scaling down
Annex E (informative) - Statistical evaluation of virus titres
and reduction factors and assessment of
their validity
Annex F (informative) - Calculation of reduction factors
Annex G (informative) - Probability of detection of agents at
low concentrations
Annex ZA (informative) - Relationship between this European
Standard and the Essential Requirements
of Directive 93/42/EEC as amended by
Commission Directive 2003/32/EC
Bibliography
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.